HemoVisionAI is our flagship R&D project soon to launch as an innovative new start-up.

At Optymum SS, we are committed to building accessible and innovative life science solutions. As part of this mission, we are developing HemoVisionAI, as a next-gen digital haematology system.

HemoVisionAI is a cloud-based, AI-integrated telehaematology ecosystem built to modernise and scale blood film diagnostics. It directly addresses inefficiencies in referral pathways, the global shortage of haematologists and enables intelligent triage, solving critical pain points in both developed and resource-constrained healthcare systems. Purpose-built for haematology laboratories and healthcare providers. HemoVisionAI streamlines workflows, reduces diagnostic delays, tackles high workload and resource constraints while lowering operational costs. In a market strained by a global shortage of haematologists and morphologists, our platform delivers faster, more accurate, and scalable interpretation, unlocking significant clinical and economic value across a multi-billion-pound global healthcare landscape.

The Problem

Haematological disorders, ranging from anaemia and leukaemia to countless morphological abnormalities, impact an estimated 2.5 billion people globally. Full Blood Count (FBC) is the most ordered lab test in the world, with 10+ million performed daily. Of these, up to 2 million per day require follow-up blood film analysis; a labour-intensive process heavily dependent on a dwindling pool of expert haematologists and morphologists.

This is not just a problem in low-resource settings. Even advanced healthcare systems face rising demand, outdated workflows, and critical workforce shortages, resulting in delays, diagnostic errors, and costly inefficiencies. Manual, paper-based referrals (often involving handwritten forms, phone calls, and unstructured emails) create significant bottlenecks, poor traceability, and inconsistent turnaround times.

These systemic inefficiencies present a massive, largely untapped opportunity to modernise an essential diagnostic workflow.

.

Our Solution: HemoVisionAI

Our answer brings together three tightly linked layers, using a roadmap that has been updated to better align with user feedback and current system needs:

.Layer 1: HemoExchange – Building a global telehaematology marketplace

We start by building our HemoExchange layer which introduces our Morphology-as-a-Service (MaaS) model, offering healthcare providers access to a global network of external expertise for second opinions, case reviews, and remote consultations. It is a marketplace for morphology expertise, with a telehaematology infrastructure that will improve diagnostic access, especially in underserved settings and across time zones.

Layer 2: HemoRefer – Modernising the referral workflow

Our second strand focuses on modernising the workflow in high income economy laboratories by replacing outdated, manual referral processes with HemoRefer; a secure, digital, internal workflow referral and collaboration platform, purpose-built for haematology labs. By integrating with third-party whole-slide scanners, HemoRefer allows blood films to be digitised, annotated, and seamlessly referred, even across institutions. This results in faster decisions, fewer errors, and an auditable, scalable system fit for the demands of modern healthcare. 

Layer 3: HemoInsightAI – Prioritising cases via artificial intelligence-powered triage

In the final strand, HemoVisionAI evolves into an advanced AI-powered triage layer that supports both HemoRefer and HemoExchange. Rather than attempting full automation, our AI model will first focus on triaging blood films. Using advanced computer vision algorithms, the system will prioritise urgent or abnormal cases, flag morphological anomalies and reduce human workload while preserving expert oversight. This triage-first strategy ensures safe AI integration into clinical workflows while unlocking real-time value and efficiency.

.
HemoVisionAI connects all three layers on a single routing engine that ensures every blood film reaches the right expert pathway, at the right time.